Clinical Trials Logo

Cataract clinical trials

View clinical trials related to Cataract.

Filter by:

NCT ID: NCT04122651 Not yet recruiting - Cataract Clinical Trials

Toric Intraocular Lenses for Cataract Patients in the NHS

Start date: October 14, 2019
Phase: N/A
Study type: Interventional

To assess visual performance, refractive outcome, and patient satisfaction with the use of "off the shelf" toric lenses, with a set cylindrical correction of 2.00 or 4.00 diopters, and combined limbal relaxing incisions and/or off-axis intraocular lens rotation, compared to fully targeted toric intraocular lens correction.

NCT ID: NCT04120987 Withdrawn - Dry Eye Clinical Trials

Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra

Start date: May 31, 2021
Phase: Phase 4
Study type: Interventional

To determine if the use of Xiidra® reduces ocular surface inflammation in preoperative and postoperative cataract patients.

NCT ID: NCT04120818 Completed - Congenital Cataract Clinical Trials

Inflammatory Cytokines in Congenital Cataract After Lensectomy and Anterior Vitrectomy

Start date: March 4, 2016
Phase:
Study type: Observational

In this prospective study , a cohort of 58 eyes with congenital cataract from Wenzhou medical university was erolled.33 eyes with congenital cataract was after lensectomy and anterior vitrectomy as post-surger group, 26 eyes without cataract surgery as control group. The cytokines of MCP-1, VEGF, IL-1, IFN-γ, IL-1r,IL-4,IL-17, IL-2,IL-5,G-CSF,IL-12, IL-15 was evaluated

NCT ID: NCT04120389 Recruiting - Cataract Clinical Trials

Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Complicated and Combined Cataract Surgery

Start date: March 13, 2020
Phase: N/A
Study type: Interventional

To study the efficacy of an ocular bandage contact lens for the treatment of dry eye after complicated and combined cataract surgery

NCT ID: NCT04104256 Enrolling by invitation - Clinical trials for Pre-Operative Testing for Cataract Surgery

Using Behavioral Economics to Reduce Low-Value Care

Start date: June 24, 2021
Phase: N/A
Study type: Interventional

There is strong consensus - based on robust randomized trial data - that routine pre-operative (pre-op) testing for cataract surgery is inappropriate. Despite these widely endorsed evidence-based recommendations, most seniors undergoing cataract surgery still receive unnecessary blood testing, EKGs, and chest X-rays (CXRs); another substantial percentage even undergo nonindicated cardiac stress tests. We will integrate three new best practice alert (BPA) nudges into the University of California, Los Angeles (UCLA) Health electronic health record (EHR). The nudges are informed by behavioral economic theory and are designed to alter the choice architecture for physicians to decrease the rate of pre-op test ordering while still preserving clinician autonomy. We will conduct a pragmatic trial to evaluate whether these BPA nudges reduce low-value pre-op testing for cataract surgery.

NCT ID: NCT04100031 Completed - Cataract Clinical Trials

Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Cataract Surgery

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

To study the efficacy of an ocular bandage contact lens for the treatment of dry eye after cataract surgery

NCT ID: NCT04096131 Completed - Clinical trials for Diabetic Macular Edema

Influence of Cataract Surgery on Early DME The DICAT-II Study

DICAT-II
Start date: January 28, 2020
Phase:
Study type: Observational

To determine if cataract surgery may have an impact on the natural history of early DME (E-DME)

NCT ID: NCT04089735 Completed - Clinical trials for Ocular Inflammation and Pain After Cataract Surgery

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery

Start date: August 13, 2019
Phase: Phase 2
Study type: Interventional

This is a Phase 2a, 2-part study (designated Parts A and B) that will evaluate APP13007 dose strength and dosing frequency in a randomized double-masked fashion for comparison to the respective matching vehicle placebo. Part A will be conducted first to evaluate 0.05% APP13007 and matching vehicle placebo in an approximate 1:1 ratio in approximately 42 subjects who experience postoperative inflammation on the first day following routine, uncomplicated, cataract surgery and who meet all eligibility criteria. Based on the results of Part A, Part B of the study may be open for enrollment to evaluate 0.05% and/or 0.1% APP13007 at various dosing frequency in approximately 84 subjects, also in an approximate 1:1 ratio, active vs. placebo. In each Part, subjects will return periodically for study assessments during the treatment period and then for a follow-up visit approximately 1 week after stopping the study drug.

NCT ID: NCT04087733 Completed - Ocular Infections Clinical Trials

Effectiveness of Liposomial Ozonized-Oil for Cataract Surgery

Start date: October 1, 2019
Phase: Phase 4
Study type: Interventional

Evaluation of the antimicrobial efficacy of a liposomal ozone-based solution (OZODROP®) , vs placebo in 200 patients undergoing cataract surgery by phacoemulsification . The clinical trial will last 3 days of treatment per patient. The conjunctival swab will be taken for each of the two eyes (in treatment and control) at T0 (before starting the treatment - 3 days before the cataract surgery) and at T3 (after 3 days of treatment - immediately before the cataract surgery). The last OZODROP instillation will take place 10 minutes before taking the sample.

NCT ID: NCT04082273 Recruiting - Cataract Clinical Trials

Comparison of Femto-laser and Manually Created Clear Corneal Incisions During Cataract Surgery

Z8_CCI
Start date: August 26, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to test the hypothesis, that in terms of Surgically Induced corneal Astigmatism (SIA), Higher-order Aberrations (HOA), and wound geometry the femtosecond clear corneal incisions (CCIs) created during cataract surgery are not inferior when compared to manual CCIs. The potential risks associated with application of the femtosecond laser in this study are no greater or in most cases less than those associated with the standard manual cataract surgical procedure, and the potential benefits (such as precision and reproducibility) are greater than with the standard manual cataract surgery. Therefore, the risk-to-benefit ratio is very low, such that the potential benefits for a subject participating in this study exceed the potential risks